Latest Type 1 hypersensitivity Stories
- 90% of subjects had reduction of free IgE to below the limit of detection by the end of XmAb7195 infusion, including at lowest dose evaluated of 0.3 mg/kg - MONROVIA, Calif.,
Allegheny Health Network Study Raises Concerns About OTC Availability of Common Treatment for Allergy Symptoms PITTSBURGH, Pa (PRWEB) January 26, 2015
JDP Therapeutics Inc., a privately held specialty pharmaceutical company, is pleased to announce that the Company has successfully completed the initial Phase 3 clinical trial (ETTAU-02) on its
MISSISSAUGA, ON, Dec. 22, 2014 /PRNewswire/ - Nuvo Research Inc.
DALLAS, December 17, 2014 /PRNewswire/ -- RnRMarketResearch.com adds "Chronic Urticaria Or Hives - Pipeline Review, H2 2014" therapeutic market research report of 67 pages
TARRYTOWN, N.Y. and PARIS, Nov. 20, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S.
Exposure to peanut proteins in household dust may be a trigger of peanut allergy, according to a study published today in the Journal of Allergy and Clinical Immunology. New
When asked about medical allergies, many people check the penicillin box because they had a reaction to penicillin at one point in their lives or they were told they have a penicillin allergy. But are they really allergic?
FLORHAM PARK, N.J., Oct.
TARRYTOWN, N.Y. and PARIS, Oct. 20, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.